Cellics Therapeutics, Inc. is a biotechnology company pioneering drug delivery and therapeutics using its Cellular Nanoparticle (CNP) platform technology. Cellics’ goal is to broadly apply the proprietary CNP drug development and delivery platforms to better treat and prevent serious diseases with high unmet medical needs.
Employees: 11-50
Total raised: $7M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | CARB-X | carb-x.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.02.2022 | - | $7M | - |